These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19715414)

  • 21. Which Patent Foramen Ovales Need Closure to Prevent Cryptogenic Strokes?
    Dalen JE; Alpert JS
    Am J Med; 2018 Mar; 131(3):222-225. PubMed ID: 29175238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patent foramen ovale and cryptogenic stroke.
    Jaquis J
    Dimens Crit Care Nurs; 2007; 26(6):233-6. PubMed ID: 18090138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
    Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
    N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis.
    Stortecky S; da Costa BR; Mattle HP; Carroll J; Hornung M; Sievert H; Trelle S; Windecker S; Meier B; Jüni P
    Eur Heart J; 2015 Jan; 36(2):120-8. PubMed ID: 25112661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
    Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
    Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patent foramen ovale, systemic embolization and closure.
    Holmes DR; Cohen H; Katz WE; Reeder GS
    Curr Probl Cardiol; 2004 Feb; 29(2):56-94. PubMed ID: 15042045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PFO and stroke: what are the data?
    Wechsler LR
    Cardiol Rev; 2008; 16(1):53-7. PubMed ID: 18091402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
    Carroll JD; Saver JL; Thaler DE; Smalling RW; Berry S; MacDonald LA; Marks DS; Tirschwell DL;
    N Engl J Med; 2013 Mar; 368(12):1092-100. PubMed ID: 23514286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New aspects of paradoxical embolism.
    Lehmeyer S; Lindhoff-Last E
    Vasa; 2011 Jan; 40(1):31-40. PubMed ID: 21283971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Another addition to the tool box.
    Tuzcu EM
    Catheter Cardiovasc Interv; 2008 May; 71(6):829-30. PubMed ID: 18412080
    [No Abstract]   [Full Text] [Related]  

  • 31. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
    Majunke N; Wallenborn J; Wunderlich N; Sievert H
    Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Fragility Index in Randomized Controlled Trials for Patent Foramen Ovale Closure in Cryptogenic Stroke.
    Topcuoglu MA; Arsava EM
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1636-1639. PubMed ID: 30890394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Patent foramen ovale and cardiovascular stroke: the eternal dilemma].
    Stolfo D; Piazza R; Cassin M; Grandis U; Antonini-Canterin F; Pavan D; Nicolosi GL
    G Ital Cardiol (Rome); 2012; 13(7-8):474-89. PubMed ID: 22781374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of recurrent stroke after percutaneous closure of patent foramen ovale.
    Rudolph V; Augustin J; Hofmann T; Hamm CW; Meinertz T; Köster R; Baldus S; Franzen O
    EuroIntervention; 2014; 9(12):1418-22. PubMed ID: 24169021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous occlusion of patent foramen ovale in patients with paradoxical embolism.
    Pinto FF; Sousa L; Abreu J; Agapito A; Quininha J; Kaku S; Antunes AM
    Rev Port Cardiol; 2001; 20(7-8):747-57; discussion 759-62. PubMed ID: 11582625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patent foramen ovale: clinical manifestations and treatment.
    Kedia G; Tobis J; Lee MS
    Rev Cardiovasc Med; 2008; 9(3):168-73. PubMed ID: 18953276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patent foramen ovale and ventricular septal defect closure.
    Wahl A; Meier B
    Heart; 2009 Jan; 95(1):70-82. PubMed ID: 19047442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders.
    Collado FMS; Poulin MF; Murphy JJ; Jneid H; Kavinsky CJ
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29910192
    [No Abstract]   [Full Text] [Related]  

  • 39. Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism.
    Bannan A; Shen R; Silvestry FE; Herrmann HC
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1066-9. PubMed ID: 19670302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late presentation of CardioSEAL PFO closure device fracture and thrombus formation three years after device implantation.
    Narayan V; Puri P; Mehra AO
    J Invasive Cardiol; 2008 Aug; 20(8):E247-9. PubMed ID: 18688073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.